Page last updated: 2024-09-04

levofloxacin and Pulmonary Consumption

levofloxacin has been researched along with Pulmonary Consumption in 62 studies

Research

Studies (62)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (4.84)	18.2507
2000's	18 (29.03)	29.6817
2010's	32 (51.61)	24.3611
2020's	9 (14.52)	2.80

Authors

Authors	Studies
Boom, WH; Dietze, R; Hadad, DJ; Johnson, JL; Molino, LP; Palaci, M; Peloquin, CA	1
Chi, Z; Pan, X; Tang, W; Yin, Y; Zhao, M	1
He, Y; Li, X	1
Beresneva, AE; Kononova, TE; Novitsky, VV; Serebryakova, VA; Urazova, OI; Vasil'eva, OA; Vengerovskii, AI	1
Behr, MA; Benedetti, A; Britton, WJ; Dowdy, DW; Fox, GJ; Graham, SM; Marais, BJ; Marks, GB; Mason, P; Menzies, D; Nguyen, BH; Nguyen, CB; Nguyen, TA; Nguyen, VN; Tran, PT; Velen, K	1
Huo, F; Li, Y; Liang, Q; Ma, Y; Pang, Y; Shang, Y; Xue, Y; Zhang, F; Zhao, L	1
Dong, L; Huo, F; Li, S; Li, Y; Ma, Y; Pang, Y; Shang, Y; Xue, Y	1
E R, V; Keny, S; Lawande, D; Parrikar, A	1
Qiujing, F; Weiwei, W	1
Kawkitinarong, K; Laohapojanart, N; Ratanajamit, C; Srichana, T	1
Bate, PNN; Chiwala, G; Fang, C; Guan, P; Hameed, HMA; Hu, J; Khan, SA; Liu, J; Liu, Z; Mugweru, JN; Tan, S; Tan, Y; Wang, B; Yusuf, B; Zhang, T; Zhong, N	1
Du, J; Gao, J; Gao, M; Li, L; Liu, Y; Ma, L; Mi, F; Tang, S; Zhang, Y	1
Bouton, TC; Butler, D; Diacon, AH; Dianis, N; Eisenach, K; Gandhi, NR; Gotuzzo, E; Horsburgh, CR; Hunt, KR; Lecca, L; Martel, B; Mitnick, CD; Moreno-Martinez, A; Patientia, RF; Peloquin, CA; Phillips, PPJ; Santillan, J; Seas, C; Vargas, D; von Groote-Bidlingmaier, F	1
Ahmad, N; Ahuja, SD; Akkerman, OW; Alffenaar, JC; Anderson, LF; Baghaei, P; Bang, D; Barry, PM; Bastos, ML; Behera, D; Benedetti, A; Bisson, GP; Boeree, MJ; Bonnet, M; Brode, SK; Brust, JCM; Cai, Y; Caumes, E; Cegielski, JP; Centis, R; Chan, ED; Chan, PC; Chang, KC; Charles, M; Cirule, A; D'Ambrosio, L; Dalcolmo, MP; de Vries, G; Dheda, K; Esmail, A; Flood, J; Fox, GJ; Fréchet-Jachym, M; Fregona, G; Gayoso, R; Gegia, M; Gler, MT; Gu, S; Guglielmetti, L; Holtz, TH; Hughes, J; Isaakidis, P; Jarlsberg, L; Kempker, RR; Keshavjee, S; Khan, FA; Kipiani, M; Koenig, SP; Koh, WJ; Kritski, A; Kuksa, L; Kvasnovsky, CL; Kwak, N; Lan, Z; Lange, C; Laniado-Laborín, R; Lee, M; Leimane, V; Leung, CC; Leung, EC; Li, PZ; Lowenthal, P; Maciel, EL; Marks, SM; Mase, S; Mbuagbaw, L; Menzies, D; Migliori, GB; Milanov, V; Miller, AC; Mitnick, CD; Modongo, C; Mohr, E; Monedero, I; Nahid, P; Ndjeka, N; O'Donnell, MR; Padayatchi, N; Palmero, D; Pape, JW; Podewils, LJ; Reynolds, I; Riekstina, V; Robert, J; Rodriguez, M; Schnippel, K; Seaworth, B; Seung, KJ; Shim, TS; Singla, R; Smith, SE; Sotgiu, G; Sukhbaatar, G; Tabarsi, P; Tiberi, S; Trajman, A; Trieu, L; Udwadia, ZF; van der Werf, TS; Veziris, N; Viiklepp, P; Vilbrun, SC; Walsh, K; Westenhouse, J; Yew, WW; Yim, JJ; Zetola, NM; Zignol, M	1
Alffenaar, JC; Heysell, SK; Migliori, GB; Mpagama, S; Peloquin, CA; Skrahina, A; Sturkenboom, MGG; Touw, DJ; van den Elsen, SHJ; van der Werf, TS; Van't Boveneind-Vrubleuskaya, N	1
Kononova, TE; Novitsky, VV; Serebryakova, VA; Urazova, OI; Vengerovskii, AI	1
Bendet, P; Deshpande, D; Gumbo, T; Heysell, SK; Koeuth, T; Lee, PS; Mpagama, SG; Pasipanodya, JG; Srivastava, S	1
Ambrose, PG; Bendet, P; Bhavnani, SM; Deshpande, D; Gumbo, T; Heysell, SK; Koeuth, T; Lee, PS; Mpagama, SG; Pasipanodya, JG; Srivastava, S; Thwaites, G	1
Alffenaar, JWC; Kosterink, JGW; Pranger, AD; van der Werf, TS	1
Akagawa, S; Ishida, M; Kawashima, M; Matsui, H; Nagai, H; Ota, K; Shimada, M; Suzuki, J; Tamura, A; Yamane, A	1
Ahn, H; Ahn, JH; Cho, SN; Hahn, S; Jang, JY; Jeon, D; Jhun, BW; Jo, KW; Kang, YA; Kim, CK; Kim, DK; Kim, JS; Kim, SY; Kim, YR; Koh, WJ; Lee, JH; Lee, JY; Lee, M; Lee, SH; Lee, T; Mok, J; Park, JS; Shim, TS; Shin, S; Shin, SJ; Song, T; Won, HJ; Yim, JJ	1
Ahmed, S; Al-Shaer, MH; Alghamdi, WA; Alkabab, Y; Alsultan, A; An, G; Banu, S; Barbakadze, K; Cegielski, JP; Heysell, SK; Houpt, E; Kempker, RR; Kipiani, M; Mikiashvili, L; Peloquin, CA	1
Ahmed, I; Hasan, R; Inayat, R; Jabeen, K	1
Davies, GR; Titarenko, AF; Ziganshina, LE	1
Chan Kim, K; Choi, JC; Choi, SB; Choi, WI; Heo, EY; Hwang, YI; Jang, SH; Jeon, K; Jung, KH; Kang, YA; Ki, YW; Kim, KU; Kim, SJ; Kim, YH; Koh, WJ; Kwon, YS; Lee, CH; Lee, J; Lee, JH; Lee, SH; Lee, YS; Ryu, YJ; Shim, TS; Um, S; Yim, JJ; Yoo, KH	1
Schluger, NW	1
Gratz, J; Heysell, SK; Houpt, ER; Kibiki, GS; Kumburu, H; Mpagama, SG; Ndusilo, N; Peloquin, CA; Stroup, S	1
Anzai, M; Ikeda, N; Katsube, O; Kikkawa, Y; Nomura, Y; Numao, T; Takizawa, H	1
Araujo, MC; dos Santos, UM; Fachinelli, LR; Martins, RR; Modesto dos Santos, V; Ribeiro, KD	1
Bharti, H; Bhushan, B; Chander, R; Gupta, A; Kajal, NC; Ranga, V	1
Alsultan, A; An, G; Peloquin, CA	1
Lee, CH; Lee, LN; Lee, MC; Wang, JT; Wang, JY; Yu, MC	1
Babarina, MB; Sokolova, VI; Sychev, DA; Zaikov, DA	1
Huh, HJ; Jeon, K; Jeong, BH; Koh, WJ; Lee, H; Lee, NY; Park, HY	1
Baboolal, SO; Garcia-Prats, AJ; Hesseling, AC; Mohamed, N; Schaaf, HS; Solomons, R; van der Laan, LE; van Toorn, R; Willemse, M	1
Chaiprasert, A; Disratthakit, A; Doi, N; Leechawengwongs, M; Prammananan, T; Thaipisuttikul, I; Tribuddharat, C	1
Chen, S; Dong, L; Huang, H; Köser, CU; Moradigaravand, D; Parkhill, J; Peacock, SJ; Schön, T; Shang, Y; Wang, G; Wei, G; Yu, X	1
Kunichan, AD; Lazareva, IaV; Sokolova, GB	1
Chen, XC; Gou, JZ; Li, MZ; Peng, YZ; Tang, ZJ; Tong, XD; Yue, XH; Zhou, BP	1
Yin, X; Yu, Z	1
Hagiwara, E; Komatsu, S; Ogura, T; Sawahata, M; Sekine, A; Takahashi, H; Tsuchiya, N	1
Akagawa, S; Ariga, H; Kaneko, Y; Kawabe, Y; Kawashima, M; Kunogi, M; Machida, K; Masuda, K; Matsui, H; Matsui, Y; Nagai, H; Nagayama, N; Nakajima, Y; Ohshima, N; Shimada, M; Suzuki, J; Tamura, A; Toyota, E	1
Kato, S; Kobashi, Y; Mouri, K; Obase, Y; Oka, M	1
Bukatina, AA; Galkina, KY; Isaeva, YD; Makarova, MV; Moroz, AM; Nosova, EY	1
Covi, M; Fabbri, LM; Ferrara, G; Franco, F; Meschiari, E; Richeldi, L; Vailati, P; Velluti, G	1
Istomin, EA; Mokrousov, IV; Narvskaia, OV; Otten, TF; Vishnevskiĭ, BI	1
Chen, L; Chen, QL; Yin, JJ	1
Gao, WW; Huang, XR; Ma, Y; Pan, YX; Wang, SM; Zhang, XX	1
Li, SM; Xing, BC; Zheng, XM	1
Desmond, EP; Nieda, RR; Sanders, CA	1
Li, JH; Wang, YZ; Zhang, HJ	1
Squire, SB; Vizel, AA; Ziganshina, LE	1
Boom, WH; Charlebois, ED; Daley, CL; Debanne, SM; Dietze, R; Eisenach, KD; Hadad, DJ; Jankus, DD; Johnson, JL; Maciel, E; Palaci, M; Peloquin, CA	1
Squire, SB; Ziganshina, LE	1
Grupper, M; Potasman, I	1
Baba, T; Endo, T; Hagiwara, E; Komatsu, S; Matsumoto, Y; Nishihira, R; Ogura, T; Sato, T; Sekine, A; Shinohara, T; Sogo, Y; Takahashi, H	1
Cynamon, MH; Klemens, SP; Rogge, MC; Sharpe, CA	1
Chirgwin, KD; Cohn, DL; el-Sadr, WM; Hafner, R; Heifets, L; Jones, BE; Klein, O; Matts, JP; Medard, F; Mildvan, D; Nelson, ET; Olibrice, M; Perlman, DC; Salomon, N; Telzak, EE	1
Benson, CA; Chirgwin, KD; El-Sadr, WM; Matts, JP; Nelson, ET; Perlman, DC; Sepkowitz, KA; Telzak, EE	1
Chan, CK; Chau, CH; Lee, J; Leung, CC; Tam, CM; Wong, PC; Yew, WW	1
Hoeppner, V; Marciniuk, D; Peloquin, CA; Reid, J	1
Harada, H; Iwasaki, Y; Minagawa, T; Nagata, K; Nakagawa, M; Nakanishi, M; Natsuhara, A; Takemura, Y	1

Reviews

7 review(s) available for levofloxacin and Pulmonary Consumption

Article	Year
The treatment effect of Levofloxacin, Moxifloxacin, and Gatifloxacin contained in the conventional therapy regimen for pulmonary tuberculosis: Systematic review and network meta-analysis. Medicine, 2022, Sep-23, Volume: 101, Issue:38 Topics: Antitubercular Agents; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Moxifloxacin; Network Meta-Analysis; Tuberculosis; Tuberculosis, Pulmonary	2022
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet (London, England), 2018, 09-08, Volume: 392, Issue:10150 Topics: Amikacin; Antitubercular Agents; Capreomycin; Carbapenems; Clofazimine; Diarylquinolines; Drug Therapy, Combination; Fluoroquinolones; Humans; Kanamycin; Levofloxacin; Linezolid; Moxifloxacin; Recurrence; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2018
The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019. Drugs, 2019, Volume: 79, Issue:2 Topics: Antitubercular Agents; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Moxifloxacin; Treatment Outcome; Tuberculosis, Pulmonary	2019
Fluoroquinolones for treating tuberculosis (presumed drug-sensitive). The Cochrane database of systematic reviews, 2013, Jun-06, Issue:6 Topics: Antitubercular Agents; Ciprofloxacin; Drug Substitution; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Randomized Controlled Trials as Topic; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2013
[Pulmonary mycobacteriosis caused by Mycobacterium peregrinum in a young, healthy man]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2010, Volume: 48, Issue:11 Topics: Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Levofloxacin; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult	2010
Fluoroquinolones for treating tuberculosis. The Cochrane database of systematic reviews, 2005, Jul-20, Issue:3 Topics: Antitubercular Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Randomized Controlled Trials as Topic; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2005
Fluoroquinolones for treating tuberculosis. The Cochrane database of systematic reviews, 2008, Jan-23, Issue:1 Topics: Antitubercular Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Randomized Controlled Trials as Topic; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2008

Trials

11 trial(s) available for levofloxacin and Pulmonary Consumption

Article	Year
Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3 Topics: Adolescent; Adult; Anti-Bacterial Agents; Area Under Curve; Aza Compounds; Brazil; Female; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Quinolines; Tuberculosis, Pulmonary	2008
Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial. BMJ open, 2020, 01-02, Volume: 10, Issue:1 Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Incidence; Latent Tuberculosis; Levofloxacin; Male; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Vietnam; Young Adult	2020
Efficacy and safety of combined isoniazid-rifampicin-pyrazinamide-levofloxacin dry powder inhaler in treatment of pulmonary tuberculosis: A randomized controlled trial. Pulmonary pharmacology & therapeutics, 2021, Volume: 70 Topics: Dry Powder Inhalers; Humans; Isoniazid; Levofloxacin; Powders; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary	2021
An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial. Trials, 2017, Nov-25, Volume: 18, Issue:1 Topics: Antitubercular Agents; Clinical Protocols; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Research Design; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2017
Population Pharmacokinetic Model and Limited Sampling Strategies for Personalized Dosing of Levofloxacin in Tuberculosis Patients. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:12 Topics: Adult; Antitubercular Agents; Area Under Curve; Bayes Theorem; Drug Dosage Calculations; Drug Monitoring; Female; Humans; Levofloxacin; Male; Middle Aged; Models, Statistical; Mycobacterium tuberculosis; Precision Medicine; Tuberculosis, Pulmonary	2018
Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, m Trials, 2019, Jan-16, Volume: 20, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Equivalence Trials as Topic; Female; Humans; Levofloxacin; Linezolid; Male; Middle Aged; Multicenter Studies as Topic; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pyrazinamide; Republic of Korea; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult	2019
Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis. American journal of respiratory and critical care medicine, 2013, Oct-01, Volume: 188, Issue:7 Topics: Adult; Aged; Antitubercular Agents; Aza Compounds; Fluoroquinolones; Humans; Levofloxacin; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Republic of Korea; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult	2013
[Levofloxacin (Tavanic) in complex therapy of tuberculosis]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2009, Volume: 54, Issue:1-2 Topics: Adult; Animals; Antitubercular Agents; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Levofloxacin; Lung; Male; Mice; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Radiography; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult	2009
[Short-term effect of treatment protocol utilizing levofloxacin, pasiniazide and M. Vaccae on multi- drug resistant pulmonary tuberculosis]. Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA, 2004, Volume: 24, Issue:5 Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aminosalicylic Acid; Aminosalicylic Acids; Clinical Protocols; Drug Therapy, Combination; Female; Humans; Isoniazid; Levofloxacin; Male; Middle Aged; Ofloxacin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2004
Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2006, Volume: 10, Issue:6 Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Female; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Single-Blind Method; Tuberculosis, Pulmonary	2006
Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Tr Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 26, Issue:5 Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Levofloxacin; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Recurrence; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary	1998

Other Studies

44 other study(ies) available for levofloxacin and Pulmonary Consumption

Article	Year
Economic Evaluation of Nemonoxacin, Moxifloxacin and Levofloxacin in the Treatment of Early Community-Acquired Pneumonia with Possible Pulmonary Tuberculosis. International journal of environmental research and public health, 2022, 04-15, Volume: 19, Issue:8 Topics: Anti-Bacterial Agents; Community-Acquired Infections; Cost-Benefit Analysis; Fluoroquinolones; Humans; Levofloxacin; Moxifloxacin; Pneumonia; Quinolones; Randomized Controlled Trials as Topic; Tuberculosis, Pulmonary	2022
Effects of Levofloxacin on Blood Lymphocyte Apoptosis in Patients with Pulmonary Tuberculosis: an In Vitro Study. Bulletin of experimental biology and medicine, 2019, Volume: 168, Issue:1 Topics: Adult; Antitubercular Agents; Apoptosis; Cells, Cultured; fas Receptor; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Tuberculosis, Pulmonary	2019
Increased prevalence of levofloxacin-resistant Mycobacterium tuberculosis in China is associated with specific mutations within the gyrA gene. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 92 Topics: Adult; China; DNA Gyrase; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Prevalence; Tuberculosis, Pulmonary	2020
Specific gyrA Gene Mutations Correlate with High Prevalence of Discordant Levofloxacin Resistance in Mycobacterium tuberculosis Isolates from Beijing, China. The Journal of molecular diagnostics : JMD, 2020, Volume: 22, Issue:9 Topics: Antitubercular Agents; Beijing; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Prevalence; Retrospective Studies; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2020
Gitelman-like syndrome: A rare complication of using aminoglycosides in tuberculosis - A case report. The Indian journal of tuberculosis, 2020, Volume: 67, Issue:3 Topics: Alkalosis; Antitubercular Agents; Capreomycin; Clofazimine; Cycloserine; Deprescriptions; Ethionamide; Gitelman Syndrome; Humans; Hypocalcemia; Hypokalemia; Levofloxacin; Linezolid; Male; Middle Aged; Pyrazinamide; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Water-Electrolyte Imbalance	2020
Efficacy of moxifloxacin combined with levofloxacin in the treatment of drug-resistant tuberculosis. Pakistan journal of pharmaceutical sciences, 2020, Volume: 33, Issue:3(Special) Topics: Adult; Antibiotics, Antitubercular; Case-Control Studies; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Random Allocation; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult	2020
A recombinant selective drug-resistant M. bovis BCG enhances the bactericidal activity of a second-line anti-tuberculosis regimen. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 142 Topics: Amikacin; Animals; Antigens, Bacterial; Antitubercular Agents; BCG Vaccine; Disease Models, Animal; Drug Resistance, Bacterial; Levofloxacin; Mice, Inbred BALB C; Mice, SCID; Mycobacterium bovis; Mycobacterium tuberculosis; Plasmids; Prothionamide; Pyrazinamide; Tuberculosis, Pulmonary; Vaccines, Synthetic; Virulence	2021
Efficacy of ultra-short course chemotherapy for new smear positive drug susceptible pulmonary tuberculosis: study protocol of a multicenter randomized controlled clinical trial. BMC infectious diseases, 2017, 06-19, Volume: 17, Issue:1 Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Levofloxacin; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary	2017
In Vitro Study of the Modulatory Effects of Levofloxacin and BCG on Secretion of Proinflammatory Cytokines in Infiltrative Pulmonary Tuberculosis. Bulletin of experimental biology and medicine, 2018, Volume: 166, Issue:2 Topics: Adult; Anti-Bacterial Agents; BCG Vaccine; Case-Control Studies; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Humans; Interferon-gamma; Interleukin-12; Interleukin-2; Leukocytes, Mononuclear; Levofloxacin; Male; Middle Aged; Mycobacterium bovis; Mycobacterium tuberculosis; Primary Cell Culture; Tuberculosis, Pulmonary; Tumor Necrosis Factor-alpha	2018
Ethionamide Pharmacokinetics/Pharmacodynamics-derived Dose, the Role of MICs in Clinical Outcome, and the Resistance Arrow of Time in Multidrug-resistant Tuberculosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 11-28, Volume: 67, Issue:suppl_3 Topics: Antitubercular Agents; Ethionamide; Humans; Isoniazid; Levofloxacin; Monte Carlo Method; Mutation; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2018
Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 11-28, Volume: 67, Issue:suppl_3 Topics: Algorithms; Antitubercular Agents; Artificial Intelligence; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Levofloxacin; Microbial Sensitivity Tests; Monte Carlo Method; Mycobacterium tuberculosis; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2018
[CLINICAL EFFECTS OF INTRAVENOUSLY ADMINISTERED LEVOFLOXACIN IN PATIENTS WITH PULMONARY TUBERCULOSIS: A RETROSPECTIVE STUDY]. Kekkaku : [Tuberculosis], 2016, Volume: 91, Issue:6 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Humans; Levofloxacin; Male; Retrospective Studies; Tuberculosis, Pulmonary	2016
Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Moxifloxacin; Ofloxacin; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult	2019
Susceptibility testing of extensively drug-resistant and pre-extensively drug-resistant Mycobacterium tuberculosis against levofloxacin, linezolid, and amoxicillin-clavulanate. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6 Topics: Acetamides; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Oxazolidinones; Pakistan; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2013
Fluoroquinolones in the treatment of tuberculosis: which is best? American journal of respiratory and critical care medicine, 2013, Oct-01, Volume: 188, Issue:7 Topics: Aza Compounds; Fluoroquinolones; Humans; Levofloxacin; Moxifloxacin; Quinolines; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2013
Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2 Topics: Adolescent; Adult; Amikacin; Antitubercular Agents; Cycloserine; Ethionamide; Female; Fluoroquinolones; Humans; Kanamycin; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Sputum; Tanzania; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2014
[A case of drug-induced hypersensitivity syndrome caused by levofloxacin used for treating pulmonary tuberculosis]. Kekkaku : [Tuberculosis], 2014, Volume: 89, Issue:2 Topics: Adult; Anti-Bacterial Agents; Drug Hypersensitivity; Humans; Levofloxacin; Male; Syndrome; Tuberculosis, Pulmonary	2014
Unsuspected tuberculosis in COPD and use of levofloxacin: diagnostic challenges. Le infezioni in medicina, 2014, Volume: 22, Issue:4 Topics: Aged, 80 and over; Anti-Bacterial Agents; Antitubercular Agents; Body Mass Index; Delayed Diagnosis; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Hypertension; Levofloxacin; Mycobacterium tuberculosis; Pulmonary Disease, Chronic Obstructive; Risk Factors; Smoking; Treatment Outcome; Tuberculosis, Pulmonary	2014
Profile of adverse drug reactions in drug resistant tuberculosis from Punjab. The Indian journal of tuberculosis, 2014, Volume: 61, Issue:4 Topics: Adolescent; Adult; Aged; Antitubercular Agents; Arthralgia; Ataxia; Chemical and Drug Induced Liver Injury; Child; Cycloserine; Drug Eruptions; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Gastrointestinal Diseases; Hearing Loss; Humans; Hypothyroidism; India; Kanamycin; Levofloxacin; Male; Middle Aged; Peripheral Nervous System Diseases; Psychoses, Substance-Induced; Pyrazinamide; Severity of Illness Index; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Vision Disorders; Young Adult	2014
Limited sampling strategy and target attainment analysis for levofloxacin in patients with tuberculosis. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:7 Topics: Adolescent; Adult; Aged; Antitubercular Agents; Area Under Curve; Brazil; Humans; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Monte Carlo Method; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult	2015
Fluoroquinolone use delays tuberculosis treatment despite immediate mycobacteriology study. The European respiratory journal, 2015, Volume: 46, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Community-Acquired Infections; Female; Fluoroquinolones; Follow-Up Studies; Humans; Levofloxacin; Linear Models; Longitudinal Studies; Male; Middle Aged; Moxifloxacin; Multivariate Analysis; Mycobacterium tuberculosis; Ofloxacin; Pneumonia, Bacterial; Taiwan; Tuberculosis, Pulmonary; Young Adult	2015
[Prospects of Levofloxacin Use in Therapy of Patients with Bronchopulmonary Diseases or Skin and Soft Tissue Pyo-Inflammatory Lesions]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2014, Volume: 59, Issue:11-12 Topics: Adult; Anti-Bacterial Agents; Bronchitis; Dose-Response Relationship, Drug; Female; Humans; Levofloxacin; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Severity of Illness Index; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult	2014
Treatment Outcomes with Fluoroquinolone-Containing Regimens for Isoniazid-Resistant Pulmonary Tuberculosis. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Adult; Aged; Antitubercular Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Recurrence; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2016
Probable Levofloxacin-associated Secondary Intracranial Hypertension in a Child With Multidrug-resistant Tuberculosis. The Pediatric infectious disease journal, 2016, Volume: 35, Issue:6 Topics: Anti-Bacterial Agents; Child; Female; Humans; Intracranial Hypertension; Levofloxacin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2016
Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:9 Topics: Aminopyridines; Antitubercular Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Gatifloxacin; Gene Expression; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Thailand; Tuberculosis, Pulmonary	2016
Wild-Type and Non-Wild-Type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and Moxifloxacin. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:9 Topics: Antitubercular Agents; China; DNA Gyrase; Drug Dosage Calculations; Drug Resistance, Bacterial; Fluoroquinolones; Gene Expression; Genotype; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis, Pulmonary	2016
[The effect of CD4+ CD25+ regulatory T cell inactivation combined with levofloxacin on murine tuberculosis]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2009, Volume: 32, Issue:9 Topics: Animals; Anti-Bacterial Agents; Female; Levofloxacin; Mice; Mice, Inbred C57BL; Ofloxacin; T-Lymphocytes, Regulatory; Tuberculosis, Pulmonary	2009
Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in China. The Journal of infection, 2010, Volume: 61, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; China; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Mycobacterium tuberculosis; Ofloxacin; Sequence Analysis, DNA; Tuberculosis, Pulmonary; Young Adult	2010
[Evaluation of tuberculosis treatment including levofloxacin (LVFX) in cases who could not continue standard regimen]. Kekkaku : [Tuberculosis], 2011, Volume: 86, Issue:9 Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Bacterial; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Tuberculosis; Tuberculosis, Pulmonary	2011
Pulmonary Mycobacterium kyorinense disease showed clinical improvement following combined therapy with clarithromycin and levofloxacin. Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:14 Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Tuberculosis, Pulmonary	2012
Analysis of mutations in the gyrA and gyrB genes and their association with the resistance of Mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin. Journal of medical microbiology, 2013, Volume: 62, Issue:Pt 1 Topics: Antitubercular Agents; Aza Compounds; DNA Gyrase; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gene Expression Regulation, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Quinolines; Russia; Tuberculosis, Pulmonary	2013
Clinical use of Levofloxacin in the long-term treatment of drug resistant tuberculosis. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2002, Volume: 57, Issue:1 Topics: Adult; Aged; Anti-Infective Agents; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Mycobacterium; Ofloxacin; Tuberculosis, Female Genital; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2002
[Sensitivity to levofloxacin of Mycobacterium tuberculosis strains with various phenotype isolated from patients with newly diagnosed and chronic tuberculosis]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2002, Volume: 47, Issue:6 Topics: Anti-Infective Agents; Chronic Disease; Drug Resistance, Bacterial; Genotype; Humans; Levofloxacin; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis, Pulmonary	2002
[A study on the clinical efficacy of a combination regimen with levofloxacin and capreomycin in the treatment of multi-drug resistant pulmonary tuberculosis]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2003, Volume: 26, Issue:8 Topics: Adolescent; Adult; Antitubercular Agents; Capreomycin; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2003
[A preliminary study on the definition of resistant breakpoints of ofloxacin and levofloxacin for Mycobacterium tuberculosis]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2004, Volume: 27, Issue:2 Topics: Adolescent; Adult; Aged; Drug Resistance, Bacterial; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis, Pulmonary	2004
Validation of the use of Middlebrook 7H10 agar, BACTEC MGIT 960, and BACTEC 460 12B media for testing the susceptibility of Mycobacterium tuberculosis to levofloxacin. Journal of clinical microbiology, 2004, Volume: 42, Issue:11 Topics: Agar; Anti-Bacterial Agents; Bacteriological Techniques; Culture Media; Drug Resistance, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis, Pulmonary	2004
[Clinical observation on treatment of retreated positive tubercle bacillus pneumoconio-tuberculosis with levofloxacin]. Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases, 2004, Volume: 22, Issue:5 Topics: Aged; Anti-Bacterial Agents; Humans; Levofloxacin; Middle Aged; Ofloxacin; Pneumoconiosis; Tuberculosis, Pulmonary	2004
Fluoroquinolones in community-acquired pneumonia when tuberculosis is around: an instructive case. The American journal of the medical sciences, 2008, Volume: 335, Issue:2 Topics: Adult; Anti-Bacterial Agents; Community-Acquired Infections; Fluoroquinolones; Humans; Levofloxacin; Male; Mycobacterium tuberculosis; Ofloxacin; Pneumonia, Bacterial; Radiography; Tuberculosis, Pulmonary	2008
[Case of pneumothorax associated with pulmonary Mycobacterium fortuitum infection]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2008, Volume: 82, Issue:2 Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Combined Modality Therapy; Drainage; Drug Resistance, Bacterial; Humans; Levofloxacin; Male; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ofloxacin; Pneumonectomy; Pneumothorax; Recurrence; Treatment Outcome; Tuberculosis, Pulmonary	2008
Activity of levofloxacin in a murine model of tuberculosis. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:7 Topics: Animals; Antitubercular Agents; Culture Media; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Levofloxacin; Lung; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Quinolones; Spleen; Stereoisomerism; Tuberculosis, Pulmonary	1994
Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Hea The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 1999, Volume: 3, Issue:4 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Chi-Square Distribution; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Levofloxacin; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pilot Projects; Prospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; United States	1999
Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens. Chest, 2000, Volume: 117, Issue:3 Topics: Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Female; Hong Kong; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Recurrence; Retrospective Studies; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2000
Pharmacokinetics of antituberculosis medications delivered via percutaneous gastrojejunostomy tube. Chest, 2002, Volume: 121, Issue:1 Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Female; Gastrostomy; Humans; Jejunostomy; Levofloxacin; Ofloxacin; Rifampin; Saskatchewan; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2002
[Mycobacterium abscessus infection complicated with diabetes mellitus]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2002, Volume: 40, Issue:1 Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Diabetes Complications; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Levofloxacin; Male; Mycobacterium Infections, Nontuberculous; Ofloxacin; Tuberculosis, Pulmonary	2002